Naviscan completes enrollment for PEM trial

12/21/2008 | AuntMinnie.com (free registration)

PET developer Naviscan has finished patient enrollment for a study that would compare the sensitivity and specificity of positron emission mammography and breast MRI. The trial also aims to evaluate PEM's potential to affect patient-management options. The firm also recently attained FDA clearance for its surgical-navigation software, which is scheduled for beta testing in the next few months.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC